C19ORF55 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.95021776505655E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11488596132858E-12 |
Normal-vs-Stage2 |
2.262800E-03 |
Normal-vs-Stage3 |
1.62441000000069E-05 |
Normal-vs-Stage4 |
9.89169999999762E-05 |
Stage1-vs-Stage2 |
6.606600E-01 |
Stage1-vs-Stage3 |
2.318200E-01 |
Stage1-vs-Stage4 |
4.880400E-01 |
Stage2-vs-Stage3 |
7.540400E-01 |
Stage2-vs-Stage4 |
9.507600E-01 |
Stage3-vs-Stage4 |
7.743200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.42432765371359E-12 |
Normal-vs-AfricanAmerican |
9.60079999999808E-05 |
Normal-vs-Asian |
9.02133923119663E-12 |
Caucasian-vs-AfricanAmerican |
6.892600E-01 |
Caucasian-vs-Asian |
1.411600E-02 |
AfricanAmerican-vs-Asian |
2.227500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.76919995215275E-09 |
Normal-vs-Female |
2.40807374041196E-13 |
Male-vs-Female |
8.140700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.242900E-03 |
Normal-vs-Age(41-60Yrs) |
1.26659793764361E-11 |
Normal-vs-Age(61-80Yrs) |
6.18630002779952E-09 |
Normal-vs-Age(81-100Yrs) |
2.854300E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.218200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.972200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.892600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.751200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.840200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.613200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.46959999999907E-05 |
Normal-vs-Grade 2 |
3.72130104508983E-11 |
Normal-vs-Grade 3 |
1.50019999756168E-08 |
Normal-vs-Grade 4 |
8.352300E-04 |
Grade 1-vs-Grade 2 |
1.622340E-03 |
Grade 1-vs-Grade 3 |
2.151600E-04 |
Grade 1-vs-Grade 4 |
1.181640E-04 |
Grade 2-vs-Grade 3 |
3.015600E-01 |
Grade 2-vs-Grade 4 |
1.663780E-01 |
Grade 3-vs-Grade 4 |
5.039400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.52353693497298E-13 |
Normal-vs-ccB subtype |
1.55719999999082E-05 |
ccA subtype-vs-ccB subtype |
7.917000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.85219675339499E-11 |
Normal-vs-N1 |
2.472200E-02 |
N0-vs-N1 |
8.617200E-01 |
|
|